Extensive editing of cellular and viral double-stranded RNA structures accounts for innate immunity suppression and the proviral activity of ADAR1p150
The interferon (IFN)-mediated innate immune response is the first line of defense against
viruses. However, an IFN-stimulated gene, the adenosine deaminase acting on RNA 1 …
viruses. However, an IFN-stimulated gene, the adenosine deaminase acting on RNA 1 …
Energy status dictates PD-L1 protein abundance and anti-tumor immunity to enable checkpoint blockade
Aberrant energy status contributes to multiple metabolic diseases, including obesity,
diabetes, and cancer, but the underlying mechanism remains elusive. Here, we report that …
diabetes, and cancer, but the underlying mechanism remains elusive. Here, we report that …
Satellite repeat RNA expression in epithelial ovarian cancer associates with a tumor-immunosuppressive phenotype
RL Porter, S Sun, MN Flores, E Berzolla… - The Journal of …, 2022 - Am Soc Clin Investig
Aberrant expression of viral-like repeat elements is a common feature of epithelial cancers,
and the substantial diversity of repeat species provides a distinct view of the cancer …
and the substantial diversity of repeat species provides a distinct view of the cancer …
Type I interferons and related pathways in cell senescence
SM Frisch, IP MacFawn - Aging cell, 2020 - Wiley Online Library
This review article addresses the largely unanticipated convergence of two landmark
discoveries. The first is the discovery of interferons, critical signaling molecules for all …
discoveries. The first is the discovery of interferons, critical signaling molecules for all …
The crossroads of cancer epigenetics and immune checkpoint therapy
G Micevic, MW Bosenberg, Q Yan - Clinical Cancer Research, 2023 - AACR
Immune checkpoint inhibitors (ICI) have significantly improved treatment outcomes for
several types of cancer over the past decade, but significant challenges that limit wider …
several types of cancer over the past decade, but significant challenges that limit wider …
LTR retroelement expansion of the human cancer transcriptome and immunopeptidome revealed by de novo transcript assembly
Dysregulated endogenous retroelements (EREs) are increasingly implicated in the initiation,
progression, and immune surveillance of human cancer. However, incomplete knowledge of …
progression, and immune surveillance of human cancer. However, incomplete knowledge of …
Targeting the innate immunoreceptor RIG-I overcomes melanoma-intrinsic resistance to T cell immunotherapy
L Such, F Zhao, D Liu, B Thier… - The Journal of …, 2020 - Am Soc Clin Investig
Understanding tumor resistance to T cell immunotherapies is critical to improve patient
outcomes. Our study revealed a role for transcriptional suppression of the tumor-intrinsic …
outcomes. Our study revealed a role for transcriptional suppression of the tumor-intrinsic …
Physiological functions of RIG-I-like receptors
M Yoneyama, H Kato, T Fujita - Immunity, 2024 - cell.com
RIG-I-like receptors (RLRs) are crucial for pathogen detection and triggering immune
responses and have immense physiological importance. In this review, we first summarize …
responses and have immense physiological importance. In this review, we first summarize …
CXCL10 Produced by HPV-Positive Cervical Cancer Cells Stimulates Exosomal PDL1 Expression by Fibroblasts via CXCR3 and JAK-STAT Pathways
X Chen, H He, Y Xiao, A Hasim, J Yuan, M Ye… - Frontiers in …, 2021 - frontiersin.org
Persistent infection with human papillomavirus (HPV) and immune surveillance failure may
be the initiating factors for the carcinogenesis of cervical squamous cell carcinoma (CSCC) …
be the initiating factors for the carcinogenesis of cervical squamous cell carcinoma (CSCC) …
KLF7 promotes pancreatic cancer growth and metastasis by up-regulating ISG expression and maintaining Golgi complex integrity
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer with a dismal prognosis.
Currently, there is no effective therapy for PDAC, and a detailed molecular and functional …
Currently, there is no effective therapy for PDAC, and a detailed molecular and functional …